Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912405845> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2912405845 abstract "294 Background: Validated predictive and prognostic biomarkers are needed in PDAC. Such biomarkers could predict response and resistance early in treatment. As 95% of PDAC harbor KRAS mutations (mKRAS), plasma mKRAS has utility as a biomarker. We explored the prognostic value of mKRAS in a PDAC cohort at Memorial Sloan Kettering. Methods: 10 mL of whole blood was collected at diagnosis of localized PDAC and early interval CT scan (approx. 8 weeks). DNA was extracted with QIAamp DNA kits (Qiagen, Valencia, CA). Single locus, if tissue KRAS known, or multiplex (G12A, G12C, G12D, G12R, G12S, G12V, G13D) digital droplet PCR (ddPCR) was performed with QX200 (BioRad, Hercules, CA) ddPCR system. Disease status was determined by radiographic, CA19-9 and clinical evaluation. Results: N = 18 enrolled (median age: 65 [range 34-85]). Median time between baseline (B) and interval (I) blood was 2.53 months (range 0.9-6). One had locally recurrent disease, 2 AJCC stage IIa, 1 IIb and 14 III. Three had tissue KRAS G12D mutation, 6 G12V and 9 unknown. Eight had gemcitabine-based treatment, 10 5-FU-based and 5 radiation. See table. mKRAS and CA19-9 at B were not associated with progression free survival (PFS) or overall survival (OS). mKRAS detection at I was associated with shorter PFS/OS (P < 0.01), but CA19-9 was not. mKRAS change from B to I was also associated with PFS/OS. For every 1 copy/mL increase in the change of mKRAS from B to I, the risk of death or progression/death increased by nearly 2 fold after controlling for baseline value (p = 0.01 for OS, p = 0.03 for PFS). Four patients, all undetectable mKRAS at I, went to surgery; 2/4 resected. Conclusions: In this pilot, 59% of localized PDAC patients had detectable mKRAS at B. mKRAS detection at I and change from B to I were associated with PFS/OS supporting that mKRAS early in treatment may be a useful prognostic and predictive marker in localized PDAC. We have initiated a large prospective trial to evaluate the predictive and prognostic potential of plasma mKRAS in advanced PDAC. [Table: see text]" @default.
- W2912405845 created "2019-02-21" @default.
- W2912405845 creator A5003720799 @default.
- W2912405845 creator A5009446517 @default.
- W2912405845 creator A5015206910 @default.
- W2912405845 creator A5027467209 @default.
- W2912405845 creator A5038396374 @default.
- W2912405845 creator A5038757682 @default.
- W2912405845 creator A5043757838 @default.
- W2912405845 creator A5045756365 @default.
- W2912405845 creator A5069522876 @default.
- W2912405845 creator A5069929201 @default.
- W2912405845 creator A5076438320 @default.
- W2912405845 date "2019-02-01" @default.
- W2912405845 modified "2023-10-05" @default.
- W2912405845 title "Pilot study of plasma KRAS as a prognostic biomarker in localized pancreas ductal adenocarcinoma (PDAC)." @default.
- W2912405845 doi "https://doi.org/10.1200/jco.2019.37.4_suppl.294" @default.
- W2912405845 hasPublicationYear "2019" @default.
- W2912405845 type Work @default.
- W2912405845 sameAs 2912405845 @default.
- W2912405845 citedByCount "0" @default.
- W2912405845 crossrefType "journal-article" @default.
- W2912405845 hasAuthorship W2912405845A5003720799 @default.
- W2912405845 hasAuthorship W2912405845A5009446517 @default.
- W2912405845 hasAuthorship W2912405845A5015206910 @default.
- W2912405845 hasAuthorship W2912405845A5027467209 @default.
- W2912405845 hasAuthorship W2912405845A5038396374 @default.
- W2912405845 hasAuthorship W2912405845A5038757682 @default.
- W2912405845 hasAuthorship W2912405845A5043757838 @default.
- W2912405845 hasAuthorship W2912405845A5045756365 @default.
- W2912405845 hasAuthorship W2912405845A5069522876 @default.
- W2912405845 hasAuthorship W2912405845A5069929201 @default.
- W2912405845 hasAuthorship W2912405845A5076438320 @default.
- W2912405845 hasConcept C104451858 @default.
- W2912405845 hasConcept C121608353 @default.
- W2912405845 hasConcept C126322002 @default.
- W2912405845 hasConcept C143425029 @default.
- W2912405845 hasConcept C143998085 @default.
- W2912405845 hasConcept C146357865 @default.
- W2912405845 hasConcept C151730666 @default.
- W2912405845 hasConcept C185592680 @default.
- W2912405845 hasConcept C207103383 @default.
- W2912405845 hasConcept C2779309665 @default.
- W2912405845 hasConcept C2780210213 @default.
- W2912405845 hasConcept C2780258809 @default.
- W2912405845 hasConcept C2781182431 @default.
- W2912405845 hasConcept C2781187634 @default.
- W2912405845 hasConcept C2781197716 @default.
- W2912405845 hasConcept C44249647 @default.
- W2912405845 hasConcept C526805850 @default.
- W2912405845 hasConcept C54355233 @default.
- W2912405845 hasConcept C552990157 @default.
- W2912405845 hasConcept C55493867 @default.
- W2912405845 hasConcept C71924100 @default.
- W2912405845 hasConcept C86803240 @default.
- W2912405845 hasConcept C90924648 @default.
- W2912405845 hasConceptScore W2912405845C104451858 @default.
- W2912405845 hasConceptScore W2912405845C121608353 @default.
- W2912405845 hasConceptScore W2912405845C126322002 @default.
- W2912405845 hasConceptScore W2912405845C143425029 @default.
- W2912405845 hasConceptScore W2912405845C143998085 @default.
- W2912405845 hasConceptScore W2912405845C146357865 @default.
- W2912405845 hasConceptScore W2912405845C151730666 @default.
- W2912405845 hasConceptScore W2912405845C185592680 @default.
- W2912405845 hasConceptScore W2912405845C207103383 @default.
- W2912405845 hasConceptScore W2912405845C2779309665 @default.
- W2912405845 hasConceptScore W2912405845C2780210213 @default.
- W2912405845 hasConceptScore W2912405845C2780258809 @default.
- W2912405845 hasConceptScore W2912405845C2781182431 @default.
- W2912405845 hasConceptScore W2912405845C2781187634 @default.
- W2912405845 hasConceptScore W2912405845C2781197716 @default.
- W2912405845 hasConceptScore W2912405845C44249647 @default.
- W2912405845 hasConceptScore W2912405845C526805850 @default.
- W2912405845 hasConceptScore W2912405845C54355233 @default.
- W2912405845 hasConceptScore W2912405845C552990157 @default.
- W2912405845 hasConceptScore W2912405845C55493867 @default.
- W2912405845 hasConceptScore W2912405845C71924100 @default.
- W2912405845 hasConceptScore W2912405845C86803240 @default.
- W2912405845 hasConceptScore W2912405845C90924648 @default.
- W2912405845 hasLocation W29124058451 @default.
- W2912405845 hasOpenAccess W2912405845 @default.
- W2912405845 hasPrimaryLocation W29124058451 @default.
- W2912405845 hasRelatedWork W1967429227 @default.
- W2912405845 hasRelatedWork W1982760226 @default.
- W2912405845 hasRelatedWork W2035390137 @default.
- W2912405845 hasRelatedWork W2045475864 @default.
- W2912405845 hasRelatedWork W2120181506 @default.
- W2912405845 hasRelatedWork W2145145022 @default.
- W2912405845 hasRelatedWork W2166022333 @default.
- W2912405845 hasRelatedWork W2504716793 @default.
- W2912405845 hasRelatedWork W4230613630 @default.
- W2912405845 hasRelatedWork W2140890293 @default.
- W2912405845 isParatext "false" @default.
- W2912405845 isRetracted "false" @default.
- W2912405845 magId "2912405845" @default.
- W2912405845 workType "article" @default.